Found 18 multiple myeloma trials
A listing of multiple myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel
Participants invited to participate in a research study must have diagnosis of multiple myeloma and have been previously treated with the study drug, cilta-cel. The purpose of this research is to monitor the health status of subjects who were previously enrolled in cilta-cel.
UPCC 02423: Phase 2 study of cevostamab consolidation following BCMA CAR T cell therapy for relapsed/refractory multiple myeloma
Please refer to the protocol, Section 2 (Objectives and Endpoints) Please refer to the protocol, Section 2 (Objectives and Endpoints) Please refer to the protocol, Section 2 (Objectives and Endpoints)
UPCC 01423:First-in-Human Study of the BCL-2 Inhibitor ABBV-453 in Biomarker-Selected Subjects with Relapsed or Refractory Multiple Myeloma
Please refer to the Protocol, Section 3.1 (Objectives) Please refer to the Protocol, Section 3 (Objectives and Endpoints) Please refer to the Protocol, Section 3 (Objectives and Endpoints)
UPCC 05424: Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis
Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section3 (Objectives and Endpoints). Please refer to Protocol Section3 (Objectives and Endpoints).
UPCC 50423: A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participants with Newly Diagnosed Multiple Myeloma Who
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT). We would like to …
Phase I Study of Tasquinimod Alone and in Combination with Standard Therapy for Relapsed or Refractory Myeloma
Phase 1
The research study is being conducted to understand the effects of tasquinimod, an experimental medication, on patients with myeloma. Eligibile subject have multiple myeloma that has been previously treated and is now in need of additional treatment. Part 1 of this study evaluates tasquinimod alone. Part 2 of this study …
Janssen MajesTEC-9
Phase 3
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd in multiple myeloma patients.
Expanded Access Protocol (Eap) For Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming
This study is designed to provide patients access to their nonconforming ide-cel as a treatment option for their disease. The study will evaluate the safety and effectiveness of this therapy through the collection of information. You may or may not receive direct medical benefit from participating in this study. The …
11 - 18 of 18
- 1
- 2
